Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Drug Labels Market Outlook 2025-2034: Market Share, and Growth Analysis By Application (Prescription Drugs, OTC Drugs, Clinical Trials), By Product Type, By End User, By Technology" report has been added to ResearchAndMarkets.com's offering.
The global Drug Labels Market size is valued at USD 12.9 billion in 2024 and is projected to reach USD 20.6 billion by 2032, registering a compound annual growth rate (CAGR) of 6.05% over the forecast period. 
The drug labels market is witnessing steady growth driven by rising pharmaceutical production, regulatory compliance requirements, and demand for anti-counterfeit labelling solutions to ensure patient safety and supply chain security. Drug labels provide essential information on dosage, expiry, ingredients, and manufacturer details, and incorporate tamper-evident and track-and-trace features. Manufacturers are focusing on developing RFID-integrated, temperature-sensitive, and high-durability labels compliant with FDA and EU guidelines.
Growth is supported by expansion of generic and biologic drug manufacturing, increasing cold chain pharmaceutical logistics, and regulatory mandates for serialization and unique identification. Challenges include stringent regulatory compliance costs, design complexities for multi-language labels, and counterfeit risks requiring advanced security features. Recent developments include CCL Industries launching RFID-enabled pharmaceutical labels, Schreiner MediPharm introducing temperature-indicator labels for biologics, and UPM Raflatac enhancing tamper-evident pharmaceutical label materials.
Drug Labels Market Size Data, Trends, Growth Opportunities, and Restraining Factors
This comprehensive Drug Labels market report delivers updated market size estimates from 2024 to 2034, offering in-depth analysis of the latest Drug Labels market trends, short-term and long-term growth drivers, competitive landscape, and new business opportunities. The report presents growth forecasts across key Drug Labels types, applications, and major segments, alongside detailed insights into the current Drug Labels market scenario to support companies in formulating effective market strategies.
The Drug Labels market outlook thoroughly examines the impact of ongoing supply chain disruptions and geopolitical issues worldwide. Factors such as trade tariffs, regulatory restrictions, production losses, and the emergence of alternatives or substitutes are carefully considered in the Drug Labels market size projections. Additionally, the analysis highlights the effects of inflation and correlates past economic downturns with current Drug Labels market trends, providing actionable intelligence for stakeholders to navigate the evolving Drug Labels business environment with precision.
Market Insights
- Major trends include integration of RFID and temperature-sensitive features in drug labels for cold chain compliance and anti-counterfeiting.
- Drivers are rising pharmaceutical production, regulatory mandates for serialization and track-and-trace, and increasing biologics requiring temperature monitoring labels.
- Challenges include stringent regulatory compliance and certification costs, design complexities for multi-language labelling, and counterfeit risks requiring security feature investments.
- Companies focus on developing high-durability, compliant label materials with integrated security, temperature indicators, and RFID for supply chain visibility.
- Recent developments include CCL Industries launching RFID pharmaceutical labels, Schreiner MediPharm introducing temperature-sensitive biologics labels, and UPM Raflatac enhancing tamper-evident label materials.
What's Included in the Report
- Global Drug Labels market size and growth projections, 2024- 2034
- North America Drug Labels market size and growth forecasts, 2024- 2034 (United States, Canada, Mexico)
- Europe market size and growth forecasts, 2024- 2034 (Germany, France, United Kingdom, Italy, Spain)
- Asia-Pacific Drug Labels market size and growth forecasts, 2024- 2034 (China, India, Japan, South Korea, Australia)
- Middle East Africa Drug Labels market size and growth estimate, 2024- 2034 (Middle East, Africa)
- South and Central America Drug Labels market size and growth outlook, 2024- 2034 (Brazil, Argentina, Chile)
- Drug Labels market size, share and CAGR of key products, applications, and other verticals, 2024- 2034
- Short- and long-term Drug Labels market trends, drivers, challenges, and opportunities
- Drug Labels market insights, Porter's Five Forces analysis
- Profiles of 5 leading companies in the industry- overview, key strategies, financials, product portfolio and SWOT analysis
- Latest market news and developments
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2024 - 2032 |
| Estimated Market Value (USD) in 2024 | $12.9 Billion |
| Forecasted Market Value (USD) by 2032 | $20.6 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
Companies Featured
- CCL Industries Inc.
- 3M Company
- Schreiner Group
- Multi-Color Corporation
- WS Packaging Group Inc.
- Resource Label Group
- Weber Packaging Solutions Inc.
- Herma GmbH
- Avery Dennison Corporation
- UPM Raflatac
- Huhtamaki Oyj
- ProMach Inc.
- Sato Holdings Corporation
- Label-Aire Inc.
- Intertronix Labeling Inc.
For more information about this report visit https://www.researchandmarkets.com/r/k6jckv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
